Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cytiva MabSelect Sure™ Chromatography Media
GSA_VA

MabSelect™ SuRe™ is a protein A affinity medium for capturing MAbs at process scale with an alkali-tolerant rProtein A ligand that allows the for cost-effective sanitization protocols

Supplier:  Cytiva 17543802

Catalog No. 45-002-989


Only null left
Add to Cart
Request a Quote

Description

Description

Has an alkali-tolerant rProteain A ligand designed to enhance protease resistance to produce monoclonal antibodies

  • Withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
  • Design gives enhanced protease resistance resulting in lower ligand leakage
  • Generic elution profile for different monoclonal antibodies enables platform approach to purification
  • High-flow agarose matrix allows the processing of large feed volumes
  • Used in the commercial manufacture of monoclonal antibodies

TRUSTED_SUSTAINABILITY
Specifications

Specifications

200 mL
Stable in aqueous Buffers commonly used in Protein A Chromatography
30 mg Human lgG/mL (at 2.4 min. residence time)
<500 cm/Hoμr
7.87 in.
Certificate of Analysis
Highly Cross-Linked Agarose
20% Ethanol
For Use of Rigorous and Cost-Effective CIP and Sanitization Protocols, Manufacture of Monoclonal Antibodies
2°C to 8°C
MabSelect SuRe Media
85 μm
20 cm
<200 kPa
3 to 12
Alkali-stabilized Protein A-derived (E. coli)
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.